Drugs / Melissa officinalis
Melissa officinalis
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06214637 | Aug 2023 → Aug 2024 | parasomnia, sleep bruxism type, temporomandibular joint disorder | Federal University of Rio de Janeiro | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02870543 | Sep 2014 → Jul 2016 | parasomnia, sleep bruxism type | Federal University of Rio de Janeiro | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Melissa officinalis | “Highlighting that the prescription of Melissa officinalis will be at night, around 20/30 minutes before bedtime, respecting the indications for the medications described in the...” NCT06214637 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “homeopathic treatment with Melissa officinalis in different concentrations” NCT06214637 ↗ |
| Route | Other | “The test solutions will be administered once a day through administration in drops for children between 5 and 10 years old and for adolescents between 11 and 16 years old.” NCT06214637 ↗ |